Revolutionary weight loss drug Wegovy and anti-diabetes medication Ozempic may be linked to a rare eye disorder, according to a new study published Wednesday.
Researchers from Massachusetts General Hospital found that patients prescribed either Ozempic or Wegovy had an elevated risk of developing nonarteritic anterior ischemic optic neuropathy, or NAION.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.